Glucagon-Like Peptide-1 Receptors Agonists (GLP1 RA)

The glucagon-like peptide-1 receptors agonists (glp1ra) are a relatively new class of drugs, used for management of type 2 diabetes. this review studies the characteristics of these drugs, focusing upon their mechanism of action, intra-class differences, and utility in clinical practice. it compares them with other incretin based therapies, the dipeptidyl peptidase-iv inhibitors, and predicts future developments in the use of these molecules, while highlighting the robust indications for the use of these drugs.